Cancer proteomics: from bench to bedside
نویسندگان
چکیده
منابع مشابه
Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
Immunotherapy has been used for years in many types of cancer therapy. Recently, cancer immunotherapy has focused on mechanisms which can enhance the development of cell-mediated immunity. Anticancer medications are administered to inhibit immunosuppressive factors such as nagalase enzyme, which is produced by neoplastic cells and destroys macrophage activating factor (Gc-MAF). Anti-neoplastics...
متن کاملFROM BENCH TO BEDSIDE Proteomics and disease: opportunities and challenges
Children’s Cancer Institute Australia for Medical Research, Sydney, NSW. Maria Kavallaris, BAppSc, PhD, Group Leader and NHMRC RD Wright Fellow, Pharmacoproteomics Group, Experimental Therapeutics Program; Glenn M Marshall, MD, FRACP, Head, Molecular Carcinogenesis Program; and Director, Centre for Children’s Cancer and Blood Disorders, Sydney Children’s Hospital, Sydney, NSW. Reprints: Dr Mari...
متن کاملFrom bench to bedside
Because the microcirculation has emerged as an important reanimation target, appropriate methods to monitor the microcirculatory function are crucial. Several teams have now succeeded in crossing this bridge from bench to bedside, but the choice of the tissues of interest remains a debate. The potential accessible vascular beds that doctors could use in reanimation strategies and the relationsh...
متن کاملFrom Bench to Bedside
Since the initial experiments nearly a decade ago, remarkable progress has been made in the field of vascular gene transfer, and trials with human subjects already are under way. The potential of vascular wall gene transfer as therapy for various vascular diseases is considerable.1,2 The purpose of this review is 2-fold: (1) to delineate the methods and principles underlying vascular gene trans...
متن کاملChallenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
The emerging scientific field of proteomics encompasses the identification, characterization, and quantification of the protein content or proteome of whole cells, tissues, or body fluids. The potential for proteomic technologies to identify and quantify novel proteins in the plasma that can function as biomarkers of the presence or severity of clinical disease states holds great promise for cl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 2008
ISSN: 0007-0920,1532-1827
DOI: 10.1038/sj.bjc.6604537